Navigation Links
Study examines liver transplantation after drug induced acute liver failure
Date:7/1/2009

Liver transplantation offers a good chance for survival for patients with drug induced acute liver failure, however, certain pre-transplant factors are associated with worse outcomes. Patients who are on life support, who have elevated serum creatinine, and children whose liver failure was caused by antiepileptic drugs did not fare as well after transplantation. These findings are in the July issue of Liver Transplantation, a journal published by John Wiley & Sons. The article is also available online at Wiley Interscience (www.interscience.wiley.com).

Drug induced acute liver failure is very rare, but can be life-threatening. Acetaminophen is the most common cause, accounting for nearly half of cases in adults, but other drugs can also be responsible. For patients who are unlikely to recover spontaneously, liver transplantation is the only treatment.

Researchers, led by Ayse L. Mindikoglu, M.D., M.P.H. of the University of Maryland School of Medicine and VA Maryland Health Care System, examined the United Network for Organ Sharing (UNOS) database which contains information about outcomes of nearly all liver transplants performed in the U.S. since 1987. They planned to analyze all of the drugs associated with acute liver failure and subsequent liver transplantation, determine survival rates after transplantation, and develop a model that would predict the risk of death after transplantation for these patients.

They included 661 patients567 adults and 94 children under age 18--who were transplanted for drug induced acute liver failure between October 1, 1987, and December 31, 2006. For each case, they collected twenty recipient and six donor demographic and clinical variables from the database.

They found that the leading drug groups causing liver failure that required transplantation were acetaminophen (40 percent), antituberculosis drugs (8 percent), antiepileptics (7
'/>"/>

Contact: Sean Wagner
medicalnews@wiley.com
781-388-8550
Wiley-Blackwell
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Study Supports Wider Use of Statins
2. Study identifies biomarker that safely monitors tumor response to new brain cancer treatment
3. The European Association for the Study of the Liver renews publishing partnership with Elsevier
4. Study to see if video games can boost thinking skills in elderly
5. GIE: Gastrointestinal Endoscopy June issue study highlights
6. Study shows 1 in 25 deaths worldwide attributable to alcohol
7. Veterans Affairs Researchers Study Benefits of Robot for Ankle Rehabilitation
8. U-M study finds voice box can be preserved, even with the largest cancers
9. Clinical Study Data Indicates that Celliant Reduces Pain
10. Girls Overall Self-Worth Improves With Contact Lens Wear, Study Shows
11. New Study Shows that Prebiotics, as Used by Jackson GI Medical, Increases Lifespan by 33%

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)..., Benton Communications a...iness growth system for retailers struggling to ma... (PRWEB) November 26, 2009 -- Flu fears is the ty...es to the emergency room, according to Dr. David B...wly released business growth system – The R...
(Date:11/25/2009)...,, TORONTOandCALGARY,Nov.25/PRNewswire/-Sent...sonanceImaging(MRI)coilsandsoftwareandCalgaryScien...logies,haveintroducedawebversionofAegis(TM)Breast4...veinterfaceisthefirsttrulyzero-footprintWebclientb...tific,sPureWeb(TM)platformallowsforzero-footprinta...
(Date:11/25/2009)...,, SANFRANCISCO,Nov.25/PRNewswire/--TheBayAr...first Winter Spare the Air Alert for...acturedfirelogsoranyothersolidfuel,bothindoorsando...nhealthyairqualitytomorrow,"saidJackBroadbent,exec...sidentstorespectthehealthoftheirneighborsandfellow...
(Date:11/25/2009)..., Does stress increase blood pressure? This simp... for many years. New Stress-related gene Modulate...increase blood pressure? This simple question has.... Now new research has for the first time establi...he blood pressure response to stress in mice as we...
(Date:11/25/2009)... Survivors often plagued by neurological symptoms,...althDay News) -- Neurological side effects are amo...vors of testicular cancer who were treated with ci... , The study included 1,409 Norwegian men treat...nd 1994 who took part in a follow-up survey conduc...
Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:New stress-related gene modulates high blood pressure in mice and men 2
...F PRUSSIA, Pa., Jan. 16 Universal,Health Services...d of,Directors voted to pay a cash dividend of $0....record as of March 3, 2008., Universal Health Ser...bulatory centers nationwide and in Puerto Rico., ...
...earchers at the Johns Hopkins Brady Urological Ins...Institute in Sweden have identified an array of ge...ong with family history for the disease, appear to...kers are common and could account for nearly half ...
...chers unclear on whether it,s reluctance to submi... , WEDNESDAY, Jan. 16 (HealthDay News) -- A sy...ludes that the positive effects of these drugs are...y journals not to publish them, or a combination ...
...e first time, researchers say targeting these unit..., Jan. 16 (HealthDay News) -- Melanoma has joined ...ulation of primordial cancer stem cells, Harvard r...umor. , "The findings validate for the first time ...
...pends Half-Million Annually to Provide "Critter Co...kangaroo,fifty-six dogs, forty-five cats, two mini...three guinea pigs and more than 400 fish and birds...caring for the pets that reside at its communities...
...ent Provides for Provider Services, Inc. to fund $...he Ready-To-Drink Product to be Developed by Mill...year Purchase Agreem...oard: MBTG) today announced that it will receive $...
Other Medicine News:Health News:Gene markers located for hereditary prostate cancer 2Health News:Gene markers located for hereditary prostate cancer 3Health News: Antidepressant Effectiveness Probably Overstated: Report 2Health News: Antidepressant Effectiveness Probably Overstated: Report 3Health News:Researchers Hone in on Cancer Stem Cells for Melanoma 2Health News:Researchers Hone in on Cancer Stem Cells for Melanoma 3Health News:500-Plus Animals Part of the Team at Healthcare Organization 2Health News:Millennium Enters Into $600,000 Product Development Agreement to Fund Product Development for the $20,000,000 Purchase Agreement with Provider Services, Inc. 2
(Date:11/25/2009)...ov.25/PRNewswire/--PraxisElectronicMedicalRecordsr...ilyPhysicians,(AAFP)FamilyPracticeManagement(FPM)2...lity,healthmaintenance,anddiseasemanagement,allcri...d#1amongdoctorsindicatingtheirEMRhadapositiveeffec...numberoneinthecountryinprovidingexcellenttraininga...
(Date:11/25/2009).../PRNewswire-FirstCall/--ERT(Nasdaq: ERES ),announc...entandCEO,andKeithSchneck,theCompany,sExecutiveVic...ualPiperJaffrayHealthCareConferenceat1:30PMESTonDe...dpartiesmayaccessthepresentationbyvisitingtheCompa...astmayalsobeaccessedat http://www.corporate-ir.net...
(Date:11/25/2009)....25/PRNewswire-USNewswire/--RemediumTechnologiesIn...psseverebleeding,wonfirstprizeand$10,000intheMostP...llenge2009,companyofficialsannouncetoday. ,, Se...edium,steampitchedtheirinventionattheGSCSecuritySu..., Remedium( www.remediumtechnologies.com )isdevel...
Breaking Medicine Technology:Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Psoriasis Raises Risk of Heart Attack Stroke Death 48954 1Psoriasis Raises Risk of Heart Attack Stroke Death 48954 2First Spine Technology Awards to Recognize Excellence and Innovation 48952 1First Spine Technology Awards to Recognize Excellence and Innovation 48952 2MUHC researcher awarded 24500 000 to study pathogenesis of infectious disease 48951 1MUHC researcher awarded 24500 000 to study pathogenesis of infectious disease 48951 2
...st-hoc analysis shows nearly nine out of ten patie... at the end of 12 months, WASHINGTON, D.C., May 22... III, open-label 12-14 month extension study (303)...ogy (BSG) meeting,in Glasgow, Scotland in March 20...olerated in mild to moderate UC,patients. Today, s...
...MIRA Data Showed 57 Percent Reduction in Risk of H... One Year, ABBOTT PARK, Ill., May 22, 2007 /PRNews...from a post-hoc analysis of a pivotal study,presen...n,Washington, D.C. showing patients with moderate ...MIRA(R) (adalimumab) maintenance,therapy were almo...
Other Medicine Technology:Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 2Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 3Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 4Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 5Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 6Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 7Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 8New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 2New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 3New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 4New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 5New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 6New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 7
...t alternative to Equalizers, the patented EXP Syst...tween two different vessel configurations. With th...ly and easily adjusted for test tubes (and microce...gn for Unparalleled Comfort Pick one of our pipet...
...bility The Equalizer 384 includes all the revolu...le and equal tip spacing, choice of two software p...ration capabilities. In addition, this model allow...loading and accessing many gels and for use with 3...
PrismPipette 96-lane Starter Set
BioPette E Electronic Multi-Channel Pipettor, 10-200l
Medicine Products: